Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$3.04 - $6.01 $38,608 - $76,327
12,700 Added 63.92%
32,570 $99,000
Q2 2021

Aug 16, 2021

SELL
$5.78 - $9.6 $106,352 - $176,640
-18,400 Reduced 48.08%
19,870 $134,000
Q1 2021

May 17, 2021

BUY
$5.67 - $12.54 $96,390 - $213,180
17,000 Added 79.92%
38,270 $279,000
Q4 2020

Feb 16, 2021

BUY
$5.28 - $9.59 $112,305 - $203,979
21,270 New
21,270 $114,000

Others Institutions Holding NHWK

About NightHawk Biosciences, Inc.


  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.